Delphia (USA) Inc. - ALLOGENE THERAPEUTICS INC ownership

ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 178 filers reported holding ALLOGENE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.70 and the average weighting 0.1%.

Quarter-by-quarter ownership
Delphia (USA) Inc. ownership history of ALLOGENE THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$68,159
-48.6%
13,714
-49.0%
0.11%
-33.7%
Q1 2023$132,723
-32.7%
26,867
-14.3%
0.16%
-28.5%
Q4 2022$197,122
-21.2%
31,339
+35.4%
0.23%
-20.3%
Q3 2022$250,000
-41.9%
23,137
-38.6%
0.29%
-3.4%
Q2 2022$430,000
+205.0%
37,713
+144.1%
0.30%
+179.2%
Q1 2022$141,000
-7.8%
15,449
+51.1%
0.11%
-35.0%
Q4 2021$153,00010,2230.16%
Other shareholders
ALLOGENE THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Vida Ventures Advisors, LLC 1,798,163$26,829,00010.04%
Wildcat Capital Management, LLC 1,716,370$25,608,0004.17%
TPG GP A, LLC 18,716,306$279,247,0002.79%
Casdin Capital, LLC 2,650,000$39,538,0001.11%
Lombard Odier Asset Management (Switzerland) SA 996,116$14,862,0000.95%
Coastal Bridge Advisors, LLC 301,929$4,505,0000.94%
HARBOR CAPITAL ADVISORS, INC. 119,547$1,784,0000.65%
Pier Capital, LLC 294,968$4,401,0000.46%
Navalign, LLC 64,428$961,0000.38%
Gratus Capital, LLC 191,871$2,863,0000.26%
View complete list of ALLOGENE THERAPEUTICS INC shareholders